Skip to main content
. 2019 Jan 16;14(1):e0210703. doi: 10.1371/journal.pone.0210703

Fig 3.

Fig 3

The number and proportion of patients with IBD (A), CD (B), and UC (C) treated with biologics stratified by years. The number and proportion of IBD patients who had received or under treatment with biologics increased from 2007 to 2014 (P <0.001).